Leaders bring more than 45 years of sales and marketing leadership to the company
REDMOND, Wash.–(BUSINESS WIRE)–EndoGastric® Solutions, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the addition of two senior executives to its leadership team: Martin Reid, Vice President of Sales, and Ted Stephens, Vice President of Marketing and Professional Education.
In their respective roles, Reid and Stephens will focus on meeting increased commercial demand of the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure using EsophyX® technology, a minimally-invasive procedure for the treatment of GERD. An estimated 1 in 5 Americans suffer from GERD, or weekly heartburn and/or regurgitation.1
“With EndoGastric Solutions on a path of rapid growth, the addition of these highly experienced commercial leaders is a critical component of our ongoing commercial strategy,” said Skip Baldino, President and CEO, EndoGastric Solutions. “Both Ted and Martin bring a deep understanding of the health care industry and are committed to making the TIF procedure a core component of physicians’ treatment approach to GERD patients across the country and abroad.”
Martin Reid, Vice President of Sales
With more than 25 years of experience in health care, Reid has held a variety of positions in sales, leadership and business development throughout his career. He most recently served as Area Vice President at Olympus Corporation of the Americas. Prior to that, Reid has served as National Sales Manager at Johnson & Johnson, Sedasys; Director of Sales at Xenex Disinfection Services; Regional Sales Manager at Given Imaging (acquired by Medtronic GI Solutions); President of his own medical device consulting practice, Reid Agency; National Sales Manager at NeoPath, Inc.; and Regional Sales Manager at Boston Scientific Corporation. He began his career with Johnson & Johnson in the Ethicon division after graduating from Whitworth University with a Bachelor of Arts degree in business management.
Ted Stephens, Vice President of Marketing and Professional Education
Stephens brings over 20 years of diverse commercial leadership across global markets in the medical device industry, with extensive knowledge in both minimally-invasive surgery and therapeutic gastrointestinal markets. Stephens most recently served as Director of Marketing for NOVADAQ Technologies. Prior to that he was the Vice President of Global Marketing at Apollo Endosurgery where he led a global team to develop and execute marketing strategies for a portfolio of surgical and therapeutic GI products. He also spent 16 years at Ethicon Endo-Surgery with various positions in engineering, sales, sales leadership and marketing. Stephens earned his Master’s degree in Business Administration from Xavier University and a Bachelor of Science in engineering from Michigan State University.
For more information on EndoGastric Solutions and to find additional career opportunities, visit www.endogastricsolutions.com.
About Current Procedural Terminology (CPT®)
CPT codes are a listing of descriptive terms and identifying codes for reporting medical services and procedures. The purpose of CPT is to provide a uniform language that accurately describes medical, surgical, and diagnostic services. The coding serves as an effective way to provide communication among healthcare providers, patients and third parties. CPT is registered trademark of the American Medical Association.
The Federal Register posts coding and payment information specific to the CPT code, allowing patients to receive access to treatment more easily for GERD. Physicians and hospitals can reference CPT Code 43210 EGD esophagogastric fundoplasty and APC 5331 Complex GI Procedures for TIF® procedures.
NP02450-20A/-01F
